DNIB UNWIND, INC. (BIND) financial statements (2021 and earlier)

Company profile

Business Address 325 VASSAR STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:7223741536341
Cash and cash equivalents7112519262819
Short-term investments 101222273522
Other undisclosed cash, cash equivalents, and short-term investments 0(0)    
Receivables4214243
Prepaid expense  1   1
Other undisclosed current assets3112322
Total current assets:14254048586846
Noncurrent Assets
Property, plant and equipment9101010777
Restricted cash and investments     22
Other noncurrent assets     00
Other undisclosed noncurrent assets11112  
Total noncurrent assets:10101011988
TOTAL ASSETS:23355159677754
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities510109989
Accounts payable0342222
Accrued liabilities4766555
Employee-related liabilities   2212
Debt81354212
Deferred revenue and credits3334556
Other undisclosed current liabilities   (2)(2)(2)(2)
Total current liabilities:16261814131214
Noncurrent Liabilities
Long-term debt and lease obligation  91112131
Long-term debt, excluding current maturities  91112131
Liabilities, other than long-term debt, including:2234000
Deferred revenue and credits2233111
Other liabilities 011111
Other undisclosed liabilities, other than long-term debt    (1)(2)(2)
Other undisclosed noncurrent liabilities0235891
Total noncurrent liabilities:24162021223
Other undisclosed liabilities9      
Total liabilities:27303435343517
Stockholders' equity
Stockholders' equity attributable to parent, including:(3)51724344237
Common stock0000000
Additional paid in capital195195194193193190177
Accumulated other comprehensive loss(3)(3)(3)(3)(3)(3)(3)
Accumulated deficit(196)(187)(174)(166)(156)(146)(137)
Warrants and rights outstanding   678 
Other undisclosed stockholders' equity attributable to parent   (6)(7)(8) 
Total stockholders' equity:(3)51724344237
TOTAL LIABILITIES AND EQUITY:23355159677754

Income statement (P&L) ($ in millions)

6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
Gross profit:4262343
Operating expenses(12)(15)(16)(14)(13)(13)(12)
Operating loss:(8)(13)(9)(12)(10)(9)(9)
Nonoperating income (expense)(1)021(0)01
Other nonoperating income (expense)(0)(0)00(0)(0)1
Interest and debt expense(0)(1)(1)(1)(1)  
Other undisclosed loss from continuing operations before equity method investments, income taxes      (1)
Net loss:(10)(13)(8)(11)(11)(8)(9)
Other undisclosed net income attributable to parent01111 1
Net loss available to common stockholders, diluted:(9)(13)(8)(10)(10)(8)(8)

Comprehensive Income ($ in millions)

6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
Net loss:(10)(13)(8)(11)(11)(8)(9)
Other undisclosed comprehensive loss  (1)   (2)
Comprehensive loss:(10)(13)(9)(11)(11)(8)(11)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent11101(0)2
Comprehensive loss, net of tax, attributable to parent:(9)(13)(8)(11)(10)(8)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: